Apilimod (hydrochloride)
Apilimod (STA 5326) hydrochloride is a PIKFYVE kinase inhibitor that promotes NLRP3 inflammatory vesicle activation and IL-1β secretion. Apilimod hydrochloride has been shown to inhibit host cell proteases, which may prevent viral invasion but also block antiviral immune responses, potentially exacerbating immunosuppression in COVID-19.
Product Specifications
CAS Number
[870087-37-9]
Product Name Alternative
STA 5326 (hydrochloride) ; LAM-002A (free base) (hydrochloride) ; AIT-101 (hydrochloride)
UNSPSC
12352005
Target
NOD-like Receptor (NLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/apilimod-hydrochloride.html
Smiles
CC1=CC=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC4=CC=CC=N4)=N2)=C1.Cl.Cl
Molecular Formula
C23H28Cl2N6O2
Molecular Weight
491.41
References & Citations
[1]The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TCR, alpha, beta (T Cell Receptor, T-cell Receptor beta-1 Chain C Region, TRBC1, T-cell Receptor alpha Chain C Region, TRAC, TCRA) (MaxLight 550) discontinued
Lentiviral human PRKCG shRNA (UAS) - Lentiviral human PRKCG shRNA (UAS, RFP) plasmid
JNK2 (MAPK9) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI4D1]
Recombinant Saccharomyces cerevisiae Uncharacterized mitochondrial membrane protein FMP10 (FMP10)